Compound K attenuates glucose intolerance and hepatic steatosis through AMPK-dependent pathways in type 2 diabetic OLETF rats

BACKGROUND/AIMS: Non-alcoholic fatty liver disease is associated with insulin resistance. Compound K (CK) is the final metabolite of panaxadiol ginsenosides that have been shown to exert antidiabetic effects. However, the molecular mechanism of the antidiabetic effects in the liver have not been elu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Yoo-Cheol, Oh, Da-Hee, Choi, Moon Chan, Lee, Sang Yeoul, Ahn, Kyu-Jeong, Chung, Ho-Yeon, Lim, Sung-Jig, Chung, Sung Hyun, Jeong, In-Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840580/
https://www.ncbi.nlm.nih.gov/pubmed/28142230
http://dx.doi.org/10.3904/kjim.2015.208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840580/
https://www.ncbi.nlm.nih.gov/pubmed/28142230
http://dx.doi.org/10.3904/kjim.2015.208

Ejemplares similares